Manufacturer:

Baxter Healthcare

Name:

DOCETAXEL

Category:

J Code

HCPCS:

J9171

NDC(s):

71288-0144-16, 71288-0144-08, 00143-9204-01, 00143-9205-01, 00409-0016-01, 00409-0201-02, 00409-0201-10, 00409-0201-20, 00409-0366-01, 00409-0367-01, 00409-0368-01, 00409-1732-01, 00409-2026-01, 00409-5068-01, 00955-1020-01, 00955-1021-04, 00955-1022-08, 16729-0267-63, 16729-0267-64, 16729-0267-65, 25021-0245-01, 25021-0245-04, 43066-0001-01, 43066-0006-01, 43066-0010-01, 43598-0258-11, 43598-0610-40, 43598-0611-11, 45963-0734-54, 45963-0765-52, 47335-0323-40, 47335-0895-40, 47335-0939-40, 50742-0428-02, 50742-0431-08, 50742-0463-16, 55150-0378-01, 55150-0379-01, 55150-0380-01, 66758-0050-01, 66758-0050-02, 66758-0050-03, 66758-0950-02, 66758-0950-03, 66758-0950-04, 67457-0531-02, 67457-0532-08, 67457-0533-16, 67457-0781-08, 70700-0174-22, 70700-0175-22, 70700-0176-22, 73358-0210-08, 73358-0210-16, 00409-4235-01, 72078-0040-08, 43598-0389-57, 00409-7870-01, 00409-0365-01, 00075-8004-04,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

DOCETAXEL is a Cancer drug manufactured by Baxter Healthcare and administered via the Intravenous route of administration. The J Code: J9171 is aligned to the drug DOCETAXEL.